NEPWA
MBOT icon

New England Private Wealth Advisors’s Microbot Medical MBOT Stock Holding History

New England Private Wealth Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-41
Closed -$17K – 123
2016
Q1 		$17K Hold
41
– – 0.01% 119
2015
Q4 		$28K Buy
41
+20
+95% +$14.7K 0.01% 122
2015
Q3 		$13K Buy
+21
New +$16K 0.01% 109

Other funds holding MBOT

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New England Private Wealth Advisors's MBOT Position: Q2 2016 in Review

New England Private Wealth Advisors sold out of Microbot Medical (MBOT) in Q2 2016, closing a stake of 41 shares — an estimated $17K sold.

New England Private Wealth Advisors first reported a position in MBOT in Q3 2015 and held it in 3 quarters. The position peaked at $28K in Q4 2015. 22 funds tracked by Wall St. Rank hold MBOT as of Q2 2016.

  • New England Private Wealth Advisors reported no remaining Microbot Medical position as of Q2 2016 after selling out during the quarter.
  • New England Private Wealth Advisors sold 41 Microbot Medical shares in Q2 2016, an estimated $17K.
  • New England Private Wealth Advisors first reported a position in Microbot Medical in Q3 2015 and held it in 3 quarters.
  • New England Private Wealth Advisors's Microbot Medical position peaked at $28K in Q4 2015.
  • 22 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2016.

Based on New England Private Wealth Advisors's 13F filing for Q2 2016, filed 5 Aug 2016.